PMID: 15230292Jul 3, 2004Paper

Gene therapy in systemic lupus erythematosus

Lupus
V C KyttarisG C Tsokos

Abstract

Preclinical studies have provided proof of concept for the feasibility and efficacy of gene therapy in human systemic lupus erythematosus (SLE). Successful efforts include gene constructs that alter the expression of cytokines or limit the cognate interaction of immune cells. Other efforts may include gene modified cell transfer such as autologous B cells transfected with tolerogenic constructs or T cells in which specific molecular aberrations have been corrected.

References

Mar 1, 1992·Arthritis and Rheumatism·D DeapenT M Mack
Aug 1, 1984·Seminars in Arthritis and Rheumatism·F C ArnettW B Bias
Mar 1, 1996·The Journal of Clinical Investigation·J E SalmonR P Kimberly
Apr 20, 1999·The Journal of Clinical Investigation·B P TsaoJ I Rotter
May 6, 1999·The New England Journal of Medicine·D H PresentS J van Deventer
Sep 30, 1999·Current Opinion in Rheumatology·R G Lahita
Jul 21, 2000·The Journal of Clinical Investigation·B R LawsonA N Theofilopoulos
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M El-AmineD W Scott
Nov 14, 2000·Molecular Medicine Today·G C Tsokos, G M Kammer
Nov 18, 2000·Advances in Immunology·M C PickeringM J Walport
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·E E SolomouG C Tsokos
Apr 12, 2001·The New England Journal of Medicine·M J Walport
Dec 1, 2001·Expert Opinion on Biological Therapy·G J Prud'hommeA N Theofilopoulos
May 25, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Thomas M HerndonGeorge C Tsokos
Jul 13, 2002·Arthritis and Rheumatism·Gary M KammerGeorge C Tsokos
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Klaus TenbrockGeorge C Tsokos
May 7, 2003·Gene Therapy·R A Mageed, G J Prud'homme
Nov 5, 2003·Trends in Immunology·Betty P Tsao

❮ Previous
Next ❯

Citations

Jan 25, 2011·Rheumatology International·Achouak AchourIbtissem Ghedira
Apr 30, 2008·The Journal of Experimental Medicine·Deborah L Smith-BouvierRhonda R Voskuhl
Aug 12, 2005·Current Opinion in Rheumatology·Jennifer A Croker, Robert P Kimberly
Aug 12, 2005·Current Opinion in Rheumatology·Eva C KoffemanSalvatore Albani
Apr 4, 2006·Current Opinion in Rheumatology·Margrit WiesendangerBetty Diamond
May 25, 2006·Medicine·Nuntana KasitanonMichelle Petri
Feb 19, 2008·Current Opinion in Rheumatology·Jochanan E Naschitz, Itzhak Rosner
Dec 15, 2010·Current Opinion in Oncology·Marna G BouwhuisAlexander Mm Eggermont
Oct 4, 2008·Current Opinion in Hematology·Riccardo SaccardiAlberto Bosi
May 26, 2009·Current Opinion in Hematology·Alan Tyndall, Alois Gratwohl
Jun 15, 2005·Expert Opinion on Biological Therapy·Anne Isine Bolstad, Roland Jonsson
May 23, 2006·Seminars in Immunology·Sandeep KrishnanGeorge C Tsokos
Sep 10, 2013·PloS One·Alexandros P GrammatikosGeorge C Tsokos
Jun 17, 2016·Nature Reviews. Disease Primers·Arvind KaulGraham Hughes
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Davood RostamzadehMehdi Yousefi
Apr 6, 2005·Lupus·S Vasoo, G R V Hughes
Mar 31, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Steven P SalvatoreSurya V Seshan
Jan 31, 2018·Nature Reviews. Nephrology·Gloria E AshuntantangLiz Lightstone

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved